Across TCGA pan-cancer cohorts, MIR513A2 RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of MIR513A2’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where MIR513A2 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types MIR513A2 is over-expressed in tumor.

KIRC, KIRP, and COAD are the cancer types where MIR513A2 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in MIR513A2 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRC	Male	II,III,IV	+0.262	<.001	8	view →
KIRP	All	All	+0.157	.017	2	view →
COAD	All	II,III,IV	+0.138	.040	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

Exploration

Same gene, other analysis: MIR513A2 RNA expression & survival · all MIR513A2 data types